J. Dalmo

发表

Priming increases the anti-tumor effect and therapeutic window of 177Lu-octreotate in nude mice bearing human small intestine neuroendocrine tumor GOT1

Toshima Z. Parris, Eva Forssell-Aronsson, J. Spetz, 2017, EJNMMI Research.

Biodistribution of 177Lu-octreotate and 111In-minigastrin in female nude mice transplanted with human medullary thyroid carcinoma GOT2.

Eva Forssell-Aronsson, J. Spetz, P. Laverman, 2011, Oncology reports.

Biodistribution of 177 Lu-octreotate and 111 In-minigastrin in female nude mice transplanted with human medullary thyroid carcinoma GOT 2

Eva Forssell-Aronsson, J. Spetz, P. Laverman, 2022 .

Specific Binding and Uptake of 131I-MIBG and 111In-Octreotide in Metastatic Paraganglioma – Tools for Choice of Radionuclide Therapy

Eva Forssell-Aronsson, J. Spetz, O. Nilsson, 2012, Hormone and Metabolic Research.

Transcriptional effects of 177Lu-octreotate therapy using a priming treatment schedule on GOT1 tumor in nude mice

Toshima Z. Parris, Eva Forssell-Aronsson, J. Spetz, 2019, EJNMMI Research.

Time-dependent transcriptional response of GOT1 human small intestine neuroendocrine tumor after 177Lu[Lu]-octreotate therapy.

Toshima Z. Parris, Eva Forssell-Aronsson, J. Spetz, 2018, Nuclear medicine and biology.

Therapy of neuroendocrine tumors with 177 Lu-octreotate Human tumor cell types and models and optimization of treatment

J. Dalmo, 2014 .

Gastrointestinal stromal tumors (GISTs) express somatostatin receptors and bind radiolabeled somatostatin analogs

Eva Forssell-Aronsson, E. Kristiansson, B. Nilsson, 2013, Acta oncologica.

Evaluation of retinol binding protein 4 and carbamoylated haemoglobin as potential renal toxicity biomarkers in adult mice treated with 177Lu-octreotate

Eva Forssell-Aronsson, L. Barregard, M. Törnqvist, 2014, EJNMMI Research.